Physician profile
Sushil V Kumar
NPI 1134278427
$3,730.24
in general payments reported to CMS, 2019-2025
27 companies · $822 in 2025
The $822 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $571 · 2020: $178 · 2021: $100 · 2022: $1,092 · 2023: $472 · 2024: $495 · 2025: $822.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,717 · Entertainment: $72.59.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,716.67 |
| Entertainment | $72.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $594.71 | 2019-2024 | Eylea Hd, Eylea |
| Amgen INC. | $411.45 | 2025 | Tepezza, Uplizna |
| Genzyme Corporation | $346.37 | 2022-2025 | |
| Bausch & Lomb Americas INC. | $207.40 | 2022-2024 | Scoutpro Osmolarity System |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $207.20 | 2019-2020 | |
| Atricure, INC. | $156.25 | 2022 | |
| Abiomed | $145.77 | 2025 | |
| Sight Sciences, INC. | $143.24 | 2025 | Sion Surgical Instrument, Omni Surgical System |
| Harrow Eye, LLC | $137.35 | 2024 | Vevye, Iheezo, Triesence |
| Pfizer INC. | $135.00 | 2019 | |
| Tarsus Pharmaceuticals, INC. | $125.00 | 2024 | Xdemvy |
| Bayer Healthcare Pharmaceuticals INC. | $124.74 | 2023 | |
| Esperion Therapeutics, INC. | $122.15 | 2022 | |
| Sirtex Medical INC | $114.99 | 2022 | |
| Merck Sharp & Dohme LLC | $114.83 | 2019 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $112.39 | 2022 | |
| Janssen Pharmaceuticals, INC | $88.80 | 2022 | |
| Medtronic, INC. | $82.20 | 2024 | Azure Xt Dr Mri Surescan |
| Johnson & Johnson Surgical Vision, INC. | $80.98 | 2019 | |
| Optos, INC. | $72.59 | 2023 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Aerie Pharmaceuticals, INC. | $54.92 | 2019-2021 | |
| Apellis Pharmaceuticals, INC. | $39.68 | 2022-2023 | Syfovre |
| Alcon Vision LLC | $31.99 | 2022-2023 | Rocklatan |
| Medtronic Vascular, INC. | $31.85 | 2020 | |
| Biotissue Holdings INC. | $21.41 | 2019-2021 | |
| Lkc Technologies, INC. | $14.49 | 2024 | |
| Ocular Therapeutix, INC. | $12.49 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sushil Kumar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.